Metabolic acidosis: An unrecognized cause of morbidity in the patient with chronic kidney disease

Kidney International, Supplement

Volumn 68, Issue 96, 2005, Pages

  Bailey, James L ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Ammoniagenesis; Muscle proteolysis; Nitrogen balance; Protein degradation

Indexed keywords

2 OXOISOVALERATE DEHYDROGENASE (LIPOAMIDE); AMMONIUM CHLORIDE; BICARBONATE; INSULIN; LIOTHYRONINE; MESSENGER RNA; MIFEPRISTONE; PARATHYROID HORMONE; PHENYLALANINE; PHOSPHATE; PROTEIN; THYROXINE; ALKALI; AMINO ACID; POTASSIUM BICARBONATE; PROTEASOME; SODIUM CHLORIDE; UBIQUITIN;

ADRENALECTOMY; AMINO ACID BLOOD LEVEL; BICARBONATE BLOOD LEVEL; BODY GROWTH; BONE METABOLISM; CALCIUM BALANCE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIETARY INTAKE; GROWTH RETARDATION; HEMODIALYSIS; HUMAN; HYPOGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY TUBULE ACIDOSIS; LIOTHYRONINE BLOOD LEVEL; MESSENGER RNA SYNTHESIS; METABOLIC ACIDOSIS; NEGATIVE FEEDBACK; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTAKE; PROTEIN MALNUTRITION; PROTEIN METABOLISM; THYROXINE BLOOD LEVEL; WESTERN BLOTTING; ACIDOSIS; CHRONIC DISEASE; KIDNEY DISEASE; REVIEW; AMMONIA FORMATION; BONE MASS; CLINICAL STUDY; DISEASE SEVERITY; DISSOLUTION; DRUG ACTIVITY; DRUG INHIBITION; ENDOCRINE DISEASE; MENOPAUSAL SYNDROME; MORBIDITY; MUSCLE ATROPHY; NITROGEN BALANCE; OSTEOBLAST; OSTEOCLAST; OXIDATION; UREMIA;

ACIDOSIS; CHRONIC DISEASE; HUMANS; KIDNEY DISEASES;

EID: 26044436261     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00450.x     Document Type: Conference Paper

References (51)

1. MCSHERRY E, MORRIS RC, JR.: Attainment of normal stature with alkali therapy in infants and children with classic renal tubular acidosis. J Clin Invest 61:509-527, 1978
2. KAISER BA, POLINSKY MS, STOVER J, et al: Growth of children following the initiation of dialysis: A comparison of three dialysis modalities. Pediatric Nephrol 8:733-738, 1994
3. BRUNGGER M, HULTER HN, KRAPF R: Effect of chronic metabolic acidosis on the growth hormone/IGF-1 endocrine axis: New cause of growth hormone insensitivity in humans. Kidney Int 51:216-221, 1997
4. BUSHINSKY DA: The contribution of acidosis to renal osteodystrophy. Kidney Int 47:1816-1832, 1995
5. ALPERN RJ, SAKHAEE K: The clinical spectrum of chronic metabolic acidosis: Homeostatic mechanisms produce significant morbidity. Am J Kidney Dis 29:291-302, 1997
6. KRIEGER NS, SESSLER NE, BUSHINSKY DA: Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro. Am J Physiol 262:F442-F448, 1992
7. SEBASTIAN A, HARRIS ST, OTTAWAY JH, et al: Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate. N Engl J Med 330:1776-1781, 1994
8. LUTZ J: Calcium balance and acid-base status of women as affected by increased protein intake and by sodium bicarbonate ingestion. Am J Clin Nutr 39:281-288, 1984
9. GRAHAM KA, HOENICH NA, TARBIT M, et al: Correction of acidosis in hemodialysis patients increases the sensitivity of the parathyroid glands to calcium. J Am Soc Nephrol 8:627-632, 1997
10. LU KC, SHIEH SD, LI B, et al: Rapid correction of metabolic acidosis in chronic renal failure: Effect on parathyroid hormone activity. Nephron 67:419-424, 1994
11. MAK RHK: Renal disease, insulin resistance and glucose intolerance. Diabetes Rev 2:19-28, 1994
12. MAK RHK: Insulin resistance but IGF-1 sensitivity in chronic renal failure. Am J Physiol 271:F114-F119, 1996
13. REAICH D, GRAHAM KA, CHANNON SM, et al: Insulin-mediated changes in PD, and glucose uptake after correction of acidosis in humans with CRF. Am J Physiol 268:E121-E126, 1995
14. MAK RH: Effect of metabolic acidosis on insulin action and secretion in uremia. Kidney Int 54:603-607, 1998
15. YOUNG VR: 1987 McCollum award lecture. Kinetics of human amino acid metabolism: Nutritional implications and some lessons. Am J Clin Nutr 46:709-725, 1987
16. PRICE SR, MITCH WE: Metabolic acidosis and uremic toxicity: Protein and amino acid metabolism. Sem Nephrol 14:232-237, 1994
17. LYON DM, DUNLOP DM, STEWART CP: The alkaline treatment of chronic nephritis. Lancet 2:1009-1013, 1931
18. GIORDANO C: Use of exogenous and endogenous urea for protein synthesis in normal and uremic subjects. J Lab Clin Med 64:231-246, 1963
19. COLES GA: Body composition in chronic renal failure. Q J Med 41:25-47, 1972
20. LOWRIE EG, LEW NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of the death rate differences among facilities. Am J Kidney Dis 15:458-482, 1990
21. BAILEY JL, ENGLAND BK, LONG RC, et al: Experimental acidemia and muscle cell pH in chronic acidosis and renal failure. Am J Physiol 269:C706-C712, 1995
22. MAY RC, KELLY RA, MITCH WE: Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism. J Clin Invest 77:614-621, 1986
23. GARIBOTTO G, RUSSO R, SOFIA A, et al: Skeletal muscle protein synthesis and degradation in patients with chronic renal failure. Kidney Int 45:1432-1439, 1994
24. ISOZAKI U, MITCH WE, ENGLAND BK, PRICE SR: Protein degradation and increased mRNAs encoding proteins of the ubiquitin-proteasome proteolytic pathway in BC3H1 myocytes requires an interaction between glucocorticoids and acidification. Proc Natl Acad Sci USA 93:1967-1971, 1996
25. MAY RC, BAILEY JL, MITCH WE, et al: Glucocorticoids and acidosis stimulate protein and amino acid catabolism in vivo. Kidney Int 49:679-683, 1996
26. MITCH WE, GOLDBERG AL: Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 335:1897-1905, 1996
27. MITCH WE, MEDINA R, GREIBER S, et al: Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. J Clin Invest 93:2127-2133, 1994
28. PRICE SR, ENGLAND BK, BAILEY JL, et al: Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle. Am J Physiol 267:C955-C960, 1994
29. BAILEY JL, WANG X, ENGLAND BK, et al: The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J Clin Invest 97:1447-1453, 1996
30. DU J, MITCH WE, WANG X, PRICE SR: Glucocorticoids induce proteasome C3 subunit expression in L6 muscle cells by opposing the suppression of its transcription by NF-kappa B. J Biol Chem 275:19661-19666, 2000
31. BERGSTROM J: Why are dialysis patients malnourished? Am J Kidney Dis 26:229-241, 1995
32. MAY RC, HARA Y, KELLY RA, et al: Branched-chain amino acid metabolism in rat muscle: Abnormal regulation in acidosis. Am J Physiol 252:E712-E718, 1987
33. ENGLAND BK, GREIBER S, MITCH WE, et al: Rat muscle branched-chain ketoacid dehydrogenase activity and mRNAs increase with extracellular acidemia. Am J Physiol 268:C1395-C1400, 1995
34. PRICE SR, WANG X: Glucocorticoids and acidification independently increase transcription of branched-chain ketoacid dehydrogenase subunit genes. Miner Electrolyte Metab 25:224-227, 1999
35. WANG X, JURKOVITZ C, PRICE SR: Regulation of branched-chain ketoacid dehydrogenase flux by extracellular pH and glucocorticoids. Am J Physiol 272:C2031-C2036, 1997
36. ENGLAND BK, GREWAL M, BAILEY JL, PRICE SR: Acidosis and glucocorticoids induce branched-chain amino acid catabolism. Miner Electrolyte Metab 22:69-71, 1996
37. PRICE SR, WANG X, BAILEY JL: Tissue-specific responses of branched-chain alpha-ketoacid dehydrogenase activity in metabolic acidosis. J Am Soc Nephrol 9:1892-1898, 1998
38. BERGSTROM J: Why are dialysis patients malnourished? Am J Kidney Dis 26:229-241, 1995
39. BERGSTROM J, ALVESTRAND A, FURST P: Plasma and muscle free amino acids in maintenance hemodialysis patients without protein malnutrition. Kidney Int 38:108-114, 1990
40. MOCHIZUKI T: The effect of metabolic acidosis on amino and keto acid metabolism in chronic renal failure [in Japanese]. Nippon Jinzo Gakkai Shi 33:213-224, 1991
41. REAICH D, CHANNON SM, SCRIMGEOUR CM, GOODSHIP TH: Ammonium chloride-induced acidosis increases protein breakdown and amino acid oxidation in humans. Am J Physiol 263:E735-E739, 1992
42. REAICH D, CHANNON SM, SCRIMGEOUR CM, et al: Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation. Am J Physiol 265:E230-E235, 1993
43. PAPADOYANNAKIS NJ, STEFANIDIS CJ, MCGEOWN M: The effect of the correction of metabolic acidosis on nitrogen and potassium balance of patients with chronic renal failure. Am J Clin Nutr 40:623-627, 1984
44. GRAHAM KA, REAICH D, CHANNON SM, et al: Correction of acidosis in hemodialysis decreases whole body protein degradation. J Am Soc Nephrol 8:632-637, 1997
45. GRAHAM KA, REAICH D, CHANNON SM, et al: Correction of acidosis in CAPD decreases whole body protein degradation. Kidney Int 49:1396-1400, 1996
46. STEIN A, MOORHOUSE J, ILES-SMITH H, et al: Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int 52:1089-1095, 1997
47. PICKERING WP,PRICE SR, BIRCHER G, et al: Nutrition in CAPD: Serum bicarbonate and the ubiquitin-proteasome system in muscle. Kidney Int 61:1286-1292, 2002
48. BALLMER PE, MCNURLAN MA, HULTER HN, et al: Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J Clin Invest 95:39-45, 1995
49. BRADY JP, HASBARGEN JA: Correction of metabolic acidosis and its effect on albumin in chronic hemodialysis patients. Am J Kidney Dis 31:35-40, 1998
50. MOVILLI E, ZANI R, CARLI O, et al: Correction of metabolic acidosis increases albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: A prospective study. Nephrol Dial Transplant 13:1719-1722, 1998
51. BASTANI B, MCNEELY M, SCHMITZ PG: Serum bicarbonate is an independent determinant of protein catabolic rate in chronic hemodialysis. Am J Nephrol 16:382-385, 1996